The Technical Analyst
Select Language :
Apellis Pharmaceuticals [APLS]

Exchange: Nasdaq Global Select Sector: Healthcare Industry: Biotechnology

Apellis Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Apellis Pharmaceuticals is listed at the NASDAQ Exchange

0.68% $39.72

Last updated: 16 May 2022 @ 11:19 am


FUNDAMENTALS
MarketCap: 4 231.05 mill
EPS: -8.84
P/E: 0.000
Earnings Date: Aug 08, 2022
SharesOutstanding: 106.52 mill
Avg Daily Volume: 1.214 mill
RATING 2022-05-13
B
Neutral
RATINGDETAILS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
4/201/212/213/214/211/22
Revenuen/a
Gr.Profitn/an/a
Ebit
Asset
Debt
DISCOUNTED CASH FLOW VALUE
$48.24
(21.44%) $8.52
Date: 2022-05-16
True Range Average
+/- $3.39
( +/- 8.60%)
Range: 36.06 - 42.84
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-05-02 Grossi Federico Sell 11 250 Stock Option (Right to Buy)
2022-05-02 Grossi Federico Sell 2 500 Common Stock
2022-04-29 Deschatelets Pascal Sell 4 000 Stock Option (Right to Buy)
2022-04-29 Deschatelets Pascal Sell 11 250 Stock Option (Right to Buy)
2022-04-29 Deschatelets Pascal Sell 4 000 Common Stock
INSIDER POWER
59.75
Last 100 transactions
Buy: 912 259 | Sell: 203 897

Forecast: 12:58 - $39.92

Live Trading Signals (every 1 min)

Forecast 1: 11:28 - $39.52
Forecast 2: 12:18 - $39.63
Forecast 3: 12:58 - $39.92
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $39.72 (0.68% )
Volume 0.232 mill
Avg. Vol. 1.214 mill
% of Avg. Vol 19.08 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Apellis Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Apellis Pharmaceuticals Inc

RSI

Intraday RSI14 chart for Apellis Pharmaceuticals Inc

Last 10 Buy & Sell Signals For APLS

141 Signals | Accuracy: 22.70% | Accuracy Buy: 18.57% | Accuracy Sell: 26.76%

Avg return buy: 0.03 % | Avg return sell: -0.37 %

$1 invested is now $1.01 or 1.00% since 20-04-22

Date Signal @ Closed %
May 16 - 11:02sell$39.67$39.71 @ May 16 - 11:040.10%
May 16 - 10:31buy$39.59$39.49 @ May 16 - 11:01-0.25%
May 16 - 09:31sell$39.18$39.94 @ May 16 - 10:301.94%
May 13 - 16:51buy$39.45$39.18 @ May 16 - 09:30-0.68%
May 13 - 16:21sell$39.45$39.45 @ May 13 - 16:510.00%
May 13 - 15:59buy$39.45$39.45 @ May 13 - 16:200.00%
May 13 - 15:57sell$39.39$39.42 @ May 13 - 15:580.06%
May 13 - 15:51buy$39.43$39.35 @ May 13 - 15:53-0.20%
May 13 - 15:48sell$39.24$39.41 @ May 13 - 15:500.43%
May 13 - 15:44buy$39.48$39.34 @ May 13 - 15:47-0.37%
The Live Chart for Apellis Pharmaceuticals Inc
Profile picture for
            Apellis Pharmaceuticals Inc

APLS

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Its lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria diseases; and in Phase II clinical trials for the treatment of cold agglutinin disease, C3 glomerulopathy, IgA nephropathy, primary membranous nephropathy, and lupus nephritis. The company is also developing APL-9, which is in single ascending dose Phase I randomized, double-blind, and placebo-controlled clinical trials for the prevention of immune system activation coincident with adeno-associated virus for intravenous administration. Apellis Pharmaceuticals, Inc. has a strategic collaboration with Swedish Orphan Biovitrum AB (publ) for the advancement of pegcetacoplan, a C3 therapy for the treatment of multiple rare diseases, including paroxysmal nocturnal hemoglobinuria. The company was founded in 2009 and is based in Waltham, Massachusetts.

Last 10 Buy Signals
Date Signal @
TSCOMay 16 - 11:17$202.78
UBXMay 16 - 11:17$0.829
TLRYMay 16 - 11:17$4.92
TPTXMay 16 - 11:17$32.79
TITNMay 16 - 11:17$23.35
TMUSMay 16 - 11:17$127.73
RPRXMay 16 - 11:17$39.92
REGIMay 16 - 11:17$61.21
RETAMay 16 - 11:17$25.67
PTVEMay 16 - 11:16$10.18

Stock Peers

Company Price Change
APLS39.720.68%
AGIO22.07-0.23%
ARNA99.990.00%
HCM10.683.19%
INNV4.46-13.06%
LEGN41.324.98%
MMSI59.170.54%
NKTR3.990.00%
NUVA52.21-0.82%
OLK11.55-2.12%
SWTX38.13-2.72%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.